BrainXell at the drug discovery conference hosted by The European Laboratory Research & Innovation Group (ELRIG)
BrainXell had the opportunity to participate in the ELRIG Drug Discovery Conference 2023. This prestigious event, held in Liverpool, brought together leading experts and innovators from the pharmaceutical industry, academia, and technology sectors to discuss the latest advancements in drug discovery and development.
As a company at the forefront of neuroscience research, BrainXell was excited to showcase our cutting-edge technologies and solutions aimed at accelerating the discovery of novel therapeutics for neurological disorders. Our team had the opportunity to network with fellow researchers, exchange ideas, and forge collaborations that will drive innovation in the field.
At the conference, BrainXell’s representatives presented our latest research findings and showcased our innovative platforms for studying neural development, disease modeling, and drug screening. We highlighted the importance of leveraging human pluripotent stem cells to model complex neurological diseases in a dish, enabling more accurate disease modeling and drug screening. Additionally, we showcased our expertise in the field of microglia, the resident immune cells of the central nervous system. Microglia play a crucial role in maintaining brain homeostasis and responding to injury and disease.
Our products, including iSPCs and microglia, enable researchers to explore the complexities of the nervous system and develop targeted therapies for neurological disorders. Learn more about the event here.